Deferasirox Tablets For Oral Suspension and Recombinate recombinant
Determining the interaction of Deferasirox Tablets For Oral Suspension and Recombinate recombinant and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: deferasirox
Brand name: Exjade, Jadenu, Jadenu Sprinkle
Synonyms: Deferasirox
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: Recombinate (recombinant), Recombinate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Deferasirox Tablets For Oral Suspension-Recombivax
- Deferasirox Tablets For Oral Suspension-Recombivax HB
- Deferasirox Tablets For Oral Suspension-Recombivax HB Adult
- Deferasirox Tablets For Oral Suspension-Recombivax HB Dialysis Formulation
- Deferasirox Tablets For Oral Suspension-Recombivax HB Pediatric/Adolescent
- Deferasirox Tablets For Oral Suspension-Recort Plus
- Recombinate recombinant-Deferiprone
- Recombinate recombinant-Deferiprone Oral Solution
- Recombinate recombinant-Deferiprone Tablets
- Recombinate recombinant-Deferoxamine
- Recombinate recombinant-Deferoxamine Injection
- Recombinate recombinant-Deferoxamine Mesylate